Walton Thomas Layton 13D/13G Filings for Finch Therapeutics Group, Inc. (FNCH)

Walton Thomas Layton 13D and 13G filings for Finch Therapeutics Group, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
3:59 pm
Sale
2021-12-3113GFINCH THERAPEUTICS GROUP INC
FNCH
Walton Thomas Layton0
0.000%
-116,239decrease
(Position Closed)
Filing